Novel NCOA2/3‐rearranged low‐grade fibroblastic spindle cell tumors: A report of five cases
Open Access
- 19 September 2023
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 63 (1)
Abstract
Spindle cell mesenchymal neoplasms are a diverse and often challenging diagnostic group. While morphological impression is sufficient for some diagnoses, increasingly immunohistochemical and even molecular data is required to render an accurate diagnosis, which can lead to the characterization of new entities. We describe five cases of novel mesenchymal neoplasms with rearrangements in the NCOA2 and NCOA3 genes partnered with either CTCF or CRTC1. Three tumors occurred in the head and neck (palate, auditory canal), while the other two were in visceral organs (lung, urinary bladder). All cases occurred in adults (range 33–86) with a median age of 42 and fairly even sex distribution = (male‐to‐female = 3:2). Morphologically, they had similar features consisting of monotonous, bland spindle to ovoid cells with fascicular and reticular arrangements in a myxohyaline to collagenous stroma. However, immunophenotypically they had essentially a null phenotype, with only two tumors staining partially for CD34 and smooth muscle actin. Targeted RNA sequencing detected in‐frame CTCF::NCOA2 (one case), CRTC1::NCOA2 (two cases), and CTCF::NCOA3 (two cases) fusions. Treatment was surgical resection in all cases. Local recurrence and/or distant metastases were not observed in any case (median follow‐up, 7.5 months; range, 2–19 months). Given their morphologic, immunohistochemical, and molecular similarities, we believe that these cases may represent an emerging family of low‐grade NCOA2/3‐rearranged fibroblastic spindle cell neoplasms.Keywords
This publication has 36 references indexed in Scilit:
- Genomic profiles and CRTC1–MAML2 fusion distinguish different subtypes of mucoepidermoid carcinomaLaboratory Investigation, 2013
- A novel GTF2I/NCOA2 fusion gene emphasizes the role of NCOA2 in soft tissue angiofibroma developmentGenes, Chromosomes and Cancer, 2012
- Recurrent Rearrangement of the PHF1 Gene in Ossifying Fibromyxoid TumorsThe American Journal of Pathology, 2012
- Angiofibroma of Soft TissueAmerican Journal of Surgical Pathology, 2012
- Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genesGenes, Chromosomes and Cancer, 2012
- Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression dataGenes, Chromosomes and Cancer, 2011
- Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) familyNature Reviews Cancer, 2009
- Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomasGenes, Chromosomes and Cancer, 2007
- Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion geneLaboratory Investigation, 2005
- t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathwayNature Genetics, 2003